<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">IBUPROFEN <img border="0" src="../images/pr.gif"/></span><br/>(eye-byoo'proe-fen)<br/><span class="topboxtradename">Advil, </span><span class="topboxtradename">Amersol <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Children's Motrin, </span><span class="topboxtradename">Ibuprin, </span><span class="topboxtradename">Junior Strength Motrin Caplets, </span><span class="topboxtradename">Medipren, </span><span class="topboxtradename">Motrin, </span><span class="topboxtradename">Nuprin, </span><span class="topboxtradename">Pediaprofen, </span><span class="topboxtradename">Pamprin-IB, </span><span class="topboxtradename">Rufen, </span><span class="topboxtradename">Trendar<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">nsaid (cox-1)</span>; <span class="classification">analgesic</span>; <span class="classification">antipyretic</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mg, 200 mg, 400 mg, 600 mg, 800 mg tablets; 50 mg, 100 mg chewable tablets;; 100 mg/5 mL, 100 mg/2.5 mL suspension; 40 mg/mL drops</p>
<h1><a name="action">Actions</a></h1>
<p>Prototype of the propionic acid <small>NSAID</small>s (cox-1) inhibitor with nonsteroidal antiinflammatory activity and significant antipyretic and analgesic properties. Blocks
         prostaglandin synthesis. Ibuprofen activity also includes modulation of T-cell function, inhibition of inflammatory cell chemotaxis,
         decreased release of superoxide radicals, or increased scavenging of these compounds at inflammatory sites.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Has nonsteroidal antiinflammatory, analgesic, and antipyretic effects. Inhibits platelet aggregation and prolongs bleeding
         time but does not affect prothrombin or whole blood clotting times. Cross-sensitivity with aspirin and other nonsteroidal
         antiinflammatory drugs has been reported.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Chronic, symptomatic rheumatoid arthritis and osteoarthritis; relief of mild to moderate pain; primary dysmenorrhea; reduction
         of fever.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Gout, juvenile rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, vascular headache.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Patient in whom urticaria, severe rhinitis, bronchospasm, angioedema, nasal polyps are precipitated by aspirin or other <small>NSAID</small>s; active peptic ulcer, bleeding abnormalities. Safe use during pregnancy (category B), lactation, or children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Hypertension, history of GI ulceration, impaired hepatic or renal function, chronic renal failure, cardiac decompensation,
         patients with SLE.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Inflammatory Disease</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 400800 mg t.i.d. or q.i.d. (max: 3200 mg/d)<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 20 kg, up to 400 mg/d in divided doses; <i>2030 kg</i>, up to 600 mg/d in divided doses; <i>3040 kg</i>, up to 800 mg/d in divided doses<br/><br/><span class="indicationtitle">Mild to Moderate Pain, Dysmenorrhea</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 400 mg q46h up to 1200 mg/d<br/><br/><span class="indicationtitle">Fever</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 200400 mg t.i.d. or q.i.d. (max: 1200 mg/d)<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span>
<i>6 mo12 y</i>, 510 mg/kg q46h up to 40 mg/kg/d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give on an empty stomach, 1 h before or 2 h after meals. May be taken with meals or milk if GI intolerance occurs.</li>
<li>Ensure that chewable tablets are chewed or crushed before being swallowed.</li>
<li>
            				Note: Tablet may be crushed if patient is unable to swallow it whole and mixed with food or liquid before swallowing.
            			
         </li>
<li>Store in tightly closed, light-resistant container unless otherwise directed by manufacturer.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Headache, dizziness, light-headedness, anxiety, emotional lability, fatigue, malaise, drowsiness, anxiety, confusion, depression,
      aseptic meningitis. <span class="typehead">CV:</span> Hypertension, palpitation, congestive heart failure (patient with marginal cardiac function); peripheral edema. <span class="typehead">Special Senses:</span> Amblyopia (blurred vision, decreased visual acuity, scotomas, changes in color vision); nystagmus, visual-field defects; tinnitus,
      impaired hearing. <span class="typehead">GI:</span> Dry mouth, gingival ulcerations, dyspepsia, <span class="speceff-common">heartburn, nausea,</span> vomiting, anorexia, diarrhea, constipation, bloating, flatulence, epigastric or abdominal discomfort or pain, GI ulceration,
      <span class="speceff-common">occult blood loss.</span>
<span class="typehead">Hematologic:</span> Thrombocytopenia, neutropenia, hemolytic or <span class="speceff-life">aplastic anemia</span>, leukopenia; decreased Hgb, Hct; transitory rise in AST, ALT, serum alkaline phosphatase; rise in (Ivy) bleeding time. <span class="typehead">GU:</span> Acute renal failure, polyuria, azotemia, cystitis, hematuria, nephrotoxicity, decreased creatinine clearance. <span class="typehead">Skin:</span> Maculopapular and vesicobullous skin eruptions, erythema multiforme, pruritus, rectal itching, acne. <span class="typehead">Body as a Whole:</span> Fluid retention with edema, Stevens-Johnson syndrome, <span class="speceff-life">toxic hepatitis</span>, hypersensitivity reactions, <span class="speceff-life">anaphylaxis</span>, bronchospasm, serum sickness, SLE, angioedema. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<span class="classification">oral anticoagulants</span>, <b>heparin</b> may prolong bleeding time; may increase <b>lithium</b> and <b>methotrexate</b> toxicity. <span class="typehead">Herbal:</span>
<b>Feverfew,</b>
<b>garlic,</b>
<b>ginger,</b>
<b>ginkgo</b> may increase bleeding potential. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 80% absorbed from GI tract. <span class="typehead">Onset:</span> 1 h antipyretic effect. <span class="typehead">Peak:</span> 12 h. <span class="typehead">Duration:</span> 68 h. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted primarily in urine; some biliary excretion. <span class="typehead">Half-Life:</span> 24 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for therapeutic effectiveness. Optimum response generally occurs within 2 wk (e.g., relief of pain, stiffness, or
            swelling; or improved joint flexion and strength).
         </li>
<li>Observe patients with history of cardiac decompensation closely for evidence of fluid retention and edema.</li>
<li>Lab tests: Baseline and periodic evaluations of Hgb, renal and hepatic function, and auditory and ophthalmologic examinations
            are recommended in patients receiving prolonged or high-dose therapy.
         </li>
<li>Monitor for GI distress and S&amp;S of GI bleeding.</li>
<li>
            							Note: Symptoms of acute toxicity in children include apnea, cyanosis, response only to painful stimuli, dizziness, and nystagmus.
            						
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Notify physician immediately of passage of dark tarry stools, "coffee ground" emesis, frankly bloody emesis, or other
            GI distress, as well as blood or protein in urine, and onset of skin rash, pruritus, jaundice.
         </li>
<li>Do not drive or engage in other potentially hazardous activities until response to the drug is known.</li>
<li>Do not self-medicate with ibuprofen if taking prescribed drugs or being treated for a serious condition without consulting
            physician.
         </li>
<li>Do not give to children younger than 3 mo or for longer than 2 d without consulting physician.</li>
<li>Do not take aspirin concurrently with ibuprofen.</li>
<li>Avoid alcohol and <small>NSAID</small>s unless otherwise advised by physician. Concurrent use may increase risk of GI ulceration and bleeding tendencies.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>